BREAKING
Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 hour ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 2 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 3 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 4 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 6 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 6 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 7 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 7 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 7 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 hour ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 2 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 3 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 4 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 6 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 6 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 7 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 7 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 7 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago
ADVERTISEMENT
Market News

AutoZone (NYSE: AZO) Q1 profit declines 0.3% but beats estimates

AutoZone Inc. (NYSE: AZO) reported a 0.3% decline in earnings for the first quarter of 2020 due to an increased effective tax rate resulting from a reduced benefit from stock options exercised. However, the results exceeded analysts’ expectations. Net income declined by 0.3% to $350.3 million while earnings increased by 6.2% to $14.30 per share […]

$AZO December 10, 2019 2 min read

AutoZone Inc. (NYSE: AZO) reported a 0.3% decline in earnings for the first quarter of 2020 due to an increased effective tax rate resulting from a reduced benefit from stock options exercised. However, the results exceeded analysts’ expectations.

Net income declined by 0.3% to $350.3 million while earnings increased by 6.2% to $14.30 per share on a benefit from stock options. Revenue for the quarter grew by 6% to $2.79 billion, on strong domestic store sales.

AutoZone (AZO) Q1 2020 Earnings Review

Since the fourth quarter of 2018, AutoZone has consistently reported solid domestic store sales, riding on improved product placement. Domestic same-store stores, or sales for stores open at least one year, increased by 3.4% in Q1.

The inventory increased by 9.1% driven by new stores and increased product placement. Inventory per store was $694,000, up from $658,000 last year and $674,000 last quarter. Net inventory, defined as merchandise inventories minus accounts payable, on a per-store basis, was a negative $71,000 versus negative $59,000 last year and negative $85,000 last quarter.

For the first quarter, operating expenses, as a percentage of sales, rose to 35.8% from 35.2% a year ago, with deleverage primarily driven by domestic store payroll and benefits. The company had cash and cash equivalents as of November 23, 2019, of $158.1 million while the total debt stood at $5.29 billion and an accumulated deficit of $1.78 billion.

ADVERTISEMENT

Read: Thor Industries Q1 earnings snapshot

During the quarter, AutoZone opened 18 new stores in the US, two in Mexico and two in Brazil. As of November 23, 2019, the company had 5,790 stores in the US, 606 stores in Mexico, and 37 stores in Brazil for a total store count of 6,433.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT